TSC2 and cystic kidney disease: This mirrors the renal cystic disease observed in human TSC cases, where cysts continue to express tuberin and hamartin, differing significantly from the mechanism underlying the formation of angiomyolipomas, which exhibit inactivating mutations and Tsc gene expression loss [83].